MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

TransMedics Group Inc

Cerrado

SectorSanidad

73.03 7.29

Resumen

Variación precio

24h

Actual

Mínimo

66.95

Máximo

73.51

Métricas clave

By Trading Economics

Ingresos

2.6M

6.9M

Ventas

13M

122M

P/B

Media del Sector

64.076

63.778

BPA

0.19

Margen de beneficios

5.638

Empleados

728

EBITDA

3.2M

16M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+47.52% upside

Dividendos

By Dow Jones

Próximas Ganancias

29 abr 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-280M

2.3B

Apertura anterior

65.74

Cierre anterior

73.03

Noticias sobre sentimiento de mercado

By Acuity

90%

10%

369 / 386 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Very Strong Bullish Evidence

TransMedics Group Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

20 sept 2024, 03:29 UTC

Principales Noticias

Dow Jones Futures: Meta, Apple, Tesla Lead New Buys In Big Rally. Pay Attention To This Key Shift. -- IBD

Comparación entre iguales

Cambio de precio

TransMedics Group Inc previsión

Precio Objetivo

By TipRanks

47.52% repunte

Estimación a 12 Meses

Media 100.71 USD  47.52%

Máximo 125 USD

Mínimo 80 USD

De acuerdo con 9 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para TransMedics Group Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

9 ratings

6

Comprar

3

Mantener

0

Vender

Puntuación técnica

By Trading Central

70.33 / 73.68Soporte y Resistencia

Corto Plazo

Very Strong Bullish Evidence

Medio plazo

Very Strong Bullish Evidence

Largo Plazo

Weak Bearish Evidence

Sentimiento

By Acuity

369 / 386 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura bajista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de TransMedics Group Inc

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.